抗原	Alpha2,6-Sialyltransferase
免疫原	The C-terminal part of synthetic peptide of Rat 2,6-sialyltransferase Purification: Purified with antigen peptide
目标物种	Rat
抗体类型	多克隆抗体
抗体同种型	IgG »相配的二抗
描述	The histopathological picture of Alzheimer's disease is characterized by senile plaques and neurofibrillary tangles, and because the senile plaques form first, they are considered the initial lesion. Senile plaques are known to be formed by accumulation of -amyloid peptide (A). A peptide is produced by the cleavage of amyloid precursor protein (APP) by two types of proteolytic enzymes. The first cleavage is performed by -secretase (BACE1), and the second -secretase. It is thought that their inhibitors may be capable of serving as safe drugs for the treatment of Alzheimer's disease. In recent years a glycosyltransferase involved in the biosynthesis of sugar chains (2,6-sialyltransferase) has also been shown to be cleaved by BACE1. The cleavage site was identified at the same time, and as a result it was demonstrated that in humans it produces cleavage-type 2,6-sialyltransferase (E44 Form) and in rats it produces cleavage-type 2,6-sialyltransferase (E41 Form). This product is purified antibody which can detect Rat 2,6-sialyltransferase (C-terminal).
抗体来源	Rabbit
特异性	Cross-reacts with Human, Mouse and Rat alpha2,6-sialyltransferase

应用范围	Western Blotting (WB)
应用备注	This antibody can be used for western blotting in concentration of about 1-5ug/mL, however, the dilution rate should be optimized by each laboratories.
纯化	Antigen peptide
缓冲液	Lyophilized product from 1% BSA in PBS containing 0.05% NaN3 . Reconstitution: 1.0 mL distilled water will be added to the product, then its concentration comes to 100 ug/mL
贮藏	Lyophilized product, 5 years at 2 8 : Solution, 2 years at 20
限制	For Research Use only

Google Scholar	抗原 alpha2,6-Sialyltransferase
EMBL Harvester	在human, mouse 或 rat 基因组里搜索抗原alpha2,6-Sialyltransferase (Bioinformatic Harvester (EMBL))

alpha2,6-Sialyltransferase (rST6GalI) (Rat) antibody

概述